Charcot-Marie-Tooth disease type I diagnosed in a 5-year-old boy after vincristine neurotoxicity, resulting in maternal diagnosis

Journal of the American Osteopathic Association

Volumn 99, Issue 3, 1999, Pages 165-167

  Olek, Michael J ^a   Bordeaux, Bryan ^b   Leshner, Robert T ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Charcot Marie Tooth; Chemotherapy toxicity; Children; Hereditary; Leukemia; Neuropathy

Indexed keywords

VINCRISTINE;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CHILD; CHROMOSOME 17; EXTRACHROMOSOMAL INHERITANCE; GAIT DISORDER; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LEUKEMIA; MALE; MUSCLE WEAKNESS; NEUROPATHY; NEUROTOXICITY; PERIPHERAL NERVE;

EID: 0032942302     PISSN: 00986151     EISSN: None     Source Type: Journal    
DOI: 10.7556/jaoa.1999.99.3.165     Document Type: Article

References (8)

1. Graf WD, Chance PF, Lensch WM, Eng LJ, Lipe HP, Bird TD. Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A. Cancer 1996;77:1356-1362.
2. Dyck PJ, Lambert EH. Lower motor and primary sensory neuron disease with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch Neurol 1968;18:619-625.
3. Buchtal F, Behse F. Peroneal muscular atrophy (PMA) and related disorders. 1. Clinical manifestations as related to biopsy findings, nerve conduction and electromyography. Brain 1977;100:41-66.
4. Lupski JR, de Oca Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, et al DNA duplication associated with Charcot-Marie-Tooth disease type 1 A. Cell 1991;6621932.
5. Hogan-Dann CM, Fellmeth WG, McGuire SA, Kiley VA. Polyneuropathy following vincristine therapy in two patients with Charcot-Marie-Tooth syndrome. JAMA 1984; 252:2862-2863
6. Griffiths JD, Stark RJ, Ding JC, Cooper IA Vincristine neurotoxicity in Charcot-Marie-Tooth syndrome. Med J Aust 1985;143:305-306.
7. Dickerhoff R, Under W, Scheiber W. Severe vincristine neurotoxicity in a patient with Charcot-Marie-Tooth disease (letter). Pediatr Hematol Oncol 1988;5:61-64.
8. Neumann Y, Toren A, Rechavi G, Seifried B, Shoham NG, Mandel M, Kenet G, Sharon N, Sadeh M, Navon R. Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease. Med Pediatr Oncol 1996; 26:280-283.